The latest data from the Centers for Disease Control and Prevention (CDC) reports that more than 55% of American adults have received at least one dose of the COVID-19 vaccine, although the latest findings are about 8% of people who skip a second appointment.
Dr Gregory Poland, director of the Mayo Clinic’s Vaccine Research Group, told Fox News that the issue is less likely to be related to vaccination hesitation and more, where people are overwhelmed with busy lives.
“Whenever you need more than one drug, compliance is reduced,” Poland said in an interview. “People are busy, life is busy, I mean, obviously they got their first dose, they̵7;re not against vaccines and a lot of factors,” such as travel-related appointments. But also misinformation from the media that could lead to Tolls for vaccination, he said.
The research, published Wednesday in the New England Journal of Medicine, focused on responses from 1,000 American adults who were asked about the vaccine in February. One in five respondents indicated to the Cornell-led research team that they believed Moderna and Pfizer’s COVID-19 vaccine each provided good protection after a single jab, while 36. % Said they were not sure. Less than half said they believed the shots provided strong protection a week or two after the second dose, according to news published in the New York Times. EurekAlert.org
Don’t skip a second dose of the COVID-19 vaccine, experts warn.
Poland states that the general public may interpret media headlines reporting the effectiveness of the vaccine after a single dose.
“The media was blemished by the headline reading ‘80% efficacy after a single dose’, so people thought, ‘OK, 80% is very much like any other vaccine, I’m fine,'” he said. “And the headline declined. The fact of the fact that we do not know what performance will be at this time when faced with a new virus, we do not know how long the immune system will last. [after a single dose]. ”
Dr. Anthony Fosy, the White House’s top coronavirus consultant, during a briefing on Friday noted the percentage of Americans who did not show up at a second vaccination appointment. It is within the criteria that are often seen for other vaccines that require multiple doses.
“So far, 8%. Even if you want to see 100% adherence, 8% is within the scope of what you would see with other vaccines of any size,” Fauci later said, citing numerous studies that state “it is remarkable. Difference “in the prevention provided after the second dose compared to the first dose.
For example, earlier Israeli researchers found that the vaccine of Pfizer-BioNTech It was 57% effective against symptomatic COVID-19 14-20 days after the first dose, while the efficacy of the vaccine was increased to 94% at least one week after the second dose. Prevention of recorded infection increased from 46% to 92% after the second dose, according to research published in the New England Journal of Medicine.Similarly, separate findings were published in the same journal. Regarding Moderna’s pushrod, it was noted that T-cell responses were significantly increased to the increased protein after a second dosing.
“Again, another important distinction,” Fauci said of the findings, which he cited during a briefing on Friday.
The MODERNA COVID-19 VACCINES vaccine provider cut off medical treatment among 94% of adults older than the CDC.
Fauci also stressed that individuals with immunosuppressants, such as those battling an autoimmune disease or cancer, should take a full two-dose series if they have received the Pfizer or Moderna vaccine.
“This is very important because people with organ transplants, especially immunosuppressants, and many cancer patients, there are many people in society who use glucocorticoids for autoimmune diseases, which may not be the case.” I received a good enough response after my first meal, and we desperately need it. They’ll get a second dose, ”Fauci said.
Get the FOX NEWS app
Dr. Ann Liu, an infectious disease physician at Stanford Healthcare, told Fox News that the second dosing offers a number of benefits, such as increased antibody levels that provide a responsive response. Longer, including more specific refined antibodies
“If there are few people here and skip the second drug, it might not be very effective, but if so many people do, it could hinder the long-term herd immunity that we are trying to achieve.”
Fox News’ Alexandria Hein contributed to this report.